Asset Purchase Agreement regarding certain assets in Orphazyme A/S in restructuring Gorrissen FederspielAsset Purchase Agreement • May 16th, 2022 • Kempharm, Inc • Pharmaceutical preparations
Contract Type FiledMay 16th, 2022 Company IndustrySeller: Orphazyme A/S in restructuring, CVR no. 32 26 63 55, a company incorporated and registered under the laws of Denmark having its registered address at Ole Maaløes Vej 3, 2200 København, Denmark (the “Seller”); and